Clinical Trial Update: A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating 9MW2821 versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial carcinoma and i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• 9MW2821

Snippet

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. | Conditions: Advanced Urothelial Carcinoma | Phase 3 | Status: RECRUITING